Most stable sample size determination in clinical trials

被引:0
|
作者
Ali Karimnezhad
Ahmad Parsian
机构
[1] K. N. Toosi University of Technology,Department of Statistics and Computer Science
[2] University of Tehran,School of Mathematics, Statistics and Computer Science
来源
关键词
Bayesian robustness; Normal model; Prior uncertainty; Posterior function; Sensitivity analysis;
D O I
暂无
中图分类号
学科分类号
摘要
This paper is devoted to robust Bayes sample size determination under the quadratic loss function. The idea behind the proposed approach is that the smaller a chosen posterior functional, the more robust the posterior inference. Such desired posterior functional has been taken, in the literature, as the range of posterior mean over a class of priors but we show that dealing with the posterior mean is not the only method leading to an optimal sample size. To provide an alternative approach, we propose implementing most stable rules into the context of sample size determination. We discuss properties of the desired most stable estimate and provide some examples in the normal model. We then compare the proposed approach with that of a recent global robustness study from both numerical and theoretical aspects. We illustrate the practical utility of our proposed method by analyzing a real data set.
引用
收藏
页码:437 / 454
页数:17
相关论文
共 50 条
  • [1] Most stable sample size determination in clinical trials
    Karimnezhad, Ali
    Parsian, Ahmad
    [J]. STATISTICAL METHODS AND APPLICATIONS, 2018, 27 (03): : 437 - 454
  • [2] The determination of sample size in controlled clinical trials in ophthalmology
    Krummenauer, F
    Dick, B
    Schwenn, O
    Pfeiffer, N
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (09) : 946 - 947
  • [3] Robust Bayesian sample size determination in clinical trials
    Brutti, Pierpaolo
    De Santis, Fulvio
    Gubbiotti, Stefania
    [J]. STATISTICS IN MEDICINE, 2008, 27 (13) : 2290 - 2306
  • [4] Statistical planning of clinical trials: an emphasis on sample size determination
    Latouche, A.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S59 - S59
  • [5] ECONOMICS IN SAMPLE-SIZE DETERMINATION FOR CLINICAL-TRIALS
    TORGERSON, DJ
    RYAN, M
    RATCLIFFE, J
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1995, 88 (07): : 517 - 521
  • [6] On the sample size of clinical trials
    Papageorgiou, Spyridon N.
    [J]. JOURNAL OF ORTHODONTICS, 2018, 45 (03) : 210 - 212
  • [7] Sample size for clinical trials
    Billings, M.
    Lopez Mitnik, G.
    Dye, B. A.
    [J]. ORAL DISEASES, 2017, 23 (08) : 1013 - 1018
  • [8] Bayesian techniques for sample size determination in clinical trials: a short review
    Pezeshk, H
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2003, 12 (06) : 489 - 504
  • [9] Empirical Bayes models of Poisson clinical trials and sample size determination
    Zaslavsky, Boris G.
    [J]. PHARMACEUTICAL STATISTICS, 2010, 9 (02) : 133 - 141
  • [10] Sample size determination for clinical trials in patients with nonlinear disease progression
    Yan, X
    Su, XG
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2006, 16 (01) : 91 - 105